Artivion | CRY - Operating Profit


Artivion reported $4.79M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 1.36B 775M Sep/2026
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 4.35M 5.31M Sep/2026
Baxter International USD 314M 38M Sep/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Boston Scientific USD 1.01B 232M Sep/2026
Edwards Lifesciences USD 542.7M 23.2M Sep/2026
Inogen USD -7.79M 728K Sep/2024
Integra LifeSciences USD 42.65M 1.36M Sep/2026
J&J USD 6.47B 1B Sep/2026
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Pfizer USD 662M 5M Sep/2026
ResMed USD 454.34M 51.33M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -13.79M 3.64M Jun/2026
Teleflex USD -105.77M 178.84M Sep/2026
Terumo JPY 89.48B 58.03B Jun/2026
Trinity Biotech USD -1.79M 481K Mar/2026